Table 2.
Cytotoxicity of VHL-based PROTACs in Pancreatic Cancer Cell Lines
![]() | |||||
|---|---|---|---|---|---|
| ID | Linker | MW | cLogP | IC50 (μM) | |
| MIA PaCa-2 | BxPC-3 | ||||
| 9–4a | 799.90 | 3.82 | 14.5 ± 7.1 | >30 | |
| 9–4b | ![]() |
755.84 | 3.99 | 15.8 ± 4.6 | >30 |
Cytotoxicity of VHL-based PROTACs in Pancreatic Cancer Cell Lines
![]() | |||||
|---|---|---|---|---|---|
| ID | Linker | MW | cLogP | IC50 (μM) | |
| MIA PaCa-2 | BxPC-3 | ||||
| 9–4a | 799.90 | 3.82 | 14.5 ± 7.1 | >30 | |
| 9–4b | ![]() |
755.84 | 3.99 | 15.8 ± 4.6 | >30 |